First-in-Human Single and Multiple Dose of KLA578-1 for Injection

Clinical trial NCT07143318 · RECRUITING

Trial details

NCT number: NCT07143318
Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-06-05
Primary completion: 2026-05-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.